News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Platinum Asset Management, an investment management company, released its Q2 2026 investor letter for "Platinum International Brands Fund". A copy of the letter can be downloaded here. The fund returned over 4% in the quarter but lost 14% over the past year, primarily due …
Sharemaestro market context Price below Trend Line 52 weeks -52.3%This article details the shareholder structure of Zoetis Inc (ZTS), outlining its major shareholders and institutional holdings. It provides a breakdown of individual shareholders and their proportions, categorizes shareholders by type, and presents institutional shareholding trends over several quarters. The report also lists recent …
Bronstein, Gewirtz & Grossman LLC has announced that a class action lawsuit has been filed against Zoetis Inc. (NYSE: ZTS) on behalf of investors who purchased securities between January 14, 2025, and May 6, 2026. The lawsuit alleges that Zoetis Inc. made false and …
Zoetis (ZTS) closed at $76.92 in the latest trading session, marking a +2.08% move from the prior day. This move outpaced the S&P 500's daily gain of 0.02%. On the other hand, the Dow registered a gain of 0.51%, and the technology-centric Nasdaq decreased …
Sharemaestro market context Price below Trend Line 52 weeks -56.8%Bank of Nova Scotia significantly reduced its stake in Zoetis Inc. (NYSE:ZTS) by 19% in the first quarter, selling over 21,000 shares but retaining a holding valued at approximately $11 million. The company's stock has faced downward pressure, trading near its 52-week low after …
Sharemaestro market context Price below Trend Line 52 weeks -52.3%This article provides a revenue breakdown for Zoetis, Inc. Class A (LSX:A1KBYX), detailing its top-performing segment and geographical contributions. In the last year, the company generated €8.06 billion in revenue, with Parasiticides being the leading segment and the United States accounting for the largest …
POET Technologies Inc. stock is down significantly following the cancellation of purchase orders by Marvell's Celestial AI unit and the filing of multiple lawsuits. The lawsuits allege that POET misrepresented its U.S. tax status and confidentiality
This page provides a comprehensive overview of POET Technologies Inc. (NASDAQ:POET) stock, including its current price, historical performance, key financial metrics, and upcoming earnings dates. It also features analyst ratings, investment ideas from the TradingView community, and a list of ETFs holding POET stock, …
Glancy Prongay Wolke & Rotter LLP has announced a securities fraud class action lawsuit against Zoetis Inc. (NYSE: ZTS), inviting shareholders who suffered losses to participate. The lawsuit alleges that Zoetis made materially misleading statements between January 2025 and May 2026 by failing to …
Sharemaestro market context Price below Trend Line 52 weeks -56.8%POET Technologies Inc. (NASDAQ:POET) generated $1.07 million in revenue last year, primarily from its Semiconductor Products and Services segment. The majority of this revenue, $1.07 million, originated from the Asia region. This represents a significant increase from the previous year's performance of $41.43 thousand.
Bragar Eagel & Squire, P.C. Litigation Partners Brandon Walker and Melissa Fortunato Encourage Investors Who Suffered Losses In Zoetis (ZTS) To Contact Them Directly To Discuss Their Options If you purchased or acquired Zoetis securities between January 14, 2025 and May 6, 2026 and …
POET Technologies Inc. (NASDAQ: POET) stock is down over 8% after disappointing earnings and the escalation of a securities class action lawsuit. The lawsuit alleges misstatements about the company's PFIC tax status and a breach of a confidentiality agreement by a senior executive, which …
POET Technologies (POET) stock has seen an 86.7% gain over the past three years but appears expensive on broader valuation metrics despite being undervalued on book value compared to the semiconductor industry. The company's P/B ratio of 2.9x is below the industry average of …
Levi & Korsinsky, LLP has filed a securities class action lawsuit against Zoetis Inc. (NYSE:ZTS) on behalf of investors who suffered losses due to alleged securities fraud between January 14, 2025, and May 6, 2026. The lawsuit claims Zoetis made false statements and concealed …
Pomerantz LLP has filed a class action lawsuit against Zoetis Inc. (NYSE: ZTS) on behalf of investors who suffered losses. The lawsuit alleges securities fraud or unlawful business practices, following a significant drop in Zoetis's stock price after the company reported flat net income …
Moon Capital Management, LLC, an investment management company, released its second quarter 2025 investor letter. A copy of the letter can be downloaded here. The S&P 500 index rebounded in the second quarter, achieving a 9.6% return for the first half of the year, …
Sharemaestro market context Price below Trend Line 52 weeks -52.3%Bernstein Liebhard LLP has announced a securities fraud class action lawsuit against Zoetis Inc. (NYSE: ZTS) on behalf of investors who purchased shares between January 14, 2025, and May 6, 2026. The lawsuit alleges that Zoetis made false and misleading statements, leading to artificially …
This page provides an overview of POET Technologies Inc (POET) stock, showing its latest trading price, market capitalization, and key financial fundamentals. It also highlights recent news articles related to POET, including its involvement in a Google Capex-fueled AI rally and analyst opinions on …
NEW YORK, July 22, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Zoetis Inc. (NYSE: ZTS) between January 14, 2025 and May 6, 2026, inclusive (the “Class Period”), of the important July 27, …
Sharemaestro market context Price below Trend Line 52 weeks -52.3%POET Technologies experienced a 200% Q1 sales surge due to its Malaysia 800G ramp and Lumilens order, yet its stock is down 7.5%. The company is facing challenges including a US$400 million dilutive equity offering, multiple class-action lawsuits, and a CEO departure, all of …
This content is a community post about POET Technologies (POET.US) on the moomoo platform. It highlights that the post is for educational purposes and includes disclaimer information. The page also features sections on "Hot AI Stocks," "Crypto Stock Picks," and "ARK ETFs," suggesting related …
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Zoetis (NYSE:ZTS) has launched Portela, a long acting monoclonal antibody therapy for osteoarthritis pain …
Sharemaestro market context Price below Trend Line 52 weeks -52.3%POET Technologies, despite 202% revenue growth, faces challenges including class-action lawsuits, a CEO departure, and a dilutive offering that have kept its shares at $8.33. The article explores the potential for POET shares to reach $25 by 2027, contingent on the successful ramp-up of …
Bernstein Liebhard LLP reminds investors of Zoetis Inc. (NYSE: ZTS) that they have until July 27, 2026, to join a securities fraud class action lawsuit. The lawsuit alleges that Zoetis made false and misleading statements between January 14, 2025, and May 6, 2026, causing …
Zoetis Inc. is facing multiple class action lawsuits from shareholders who purchased securities between January 14, 2025, and May 6, 2026. The lawsuits allege that Zoetis made materially false and misleading statements that inflated stock prices, leading to significant investor losses. These claims stem …
First long-acting anti-NGF monoclonal antibody therapy for cats offers three months of osteoarthritis pain relief with a single injection PARSIPPANY, N.J., July 22, 2026--(BUSINESS WIRE)--Zoetis Inc. (NYSE: ZTS) today announced the commercial launch of Portela® (relfovetmab) in Canada and the European Union (EU) member …
Sharemaestro market context Price below Trend Line 52 weeks -52.3%In the latest close session, Zoetis (ZTS) was down 1.12% at $75.35. The stock's change was less than the S&P 500's daily gain of 0.89%. Elsewhere, the Dow gained 0.74%, while the tech-heavy Nasdaq added 1.29%. Shares of the animal health company witnessed a …
Sharemaestro market context Price below Trend Line 52 weeks -56.8%POET Technologies (POET) stock is trading up following upbeat coverage of its advanced photonics platform, with strong shareholder backing for its aggressive growth roadmap. The company plans to scale optical engine production more than 10x to 1M units per month by end-2027, funded by …
The Gross Law Firm has issued a shareholder alert for Zoetis Inc. (NYSE: ZTS), announcing a securities class action lawsuit. Investors who purchased ZTS shares between January 14, 2025, and May 6, 2026, are encouraged to contact the firm, possibly for lead plaintiff appointment. …
Sharemaestro market context Price below Trend Line 52 weeks -54.2%The Rosen Law Firm reminds investors who purchased Zoetis Inc. (NYSE: ZTS) securities between January 14, 2025, and May 6, 2026, of the July 27, 2026 lead plaintiff deadline in a securities fraud lawsuit. The lawsuit alleges that Zoetis made false and misleading statements …
Bragar Eagel & Squire, P.C. has announced a class action lawsuit against Zoetis, Inc. (NYSE:ZTS) for investors who purchased securities between January 14, 2025, and May 6, 2026. The lawsuit alleges that Zoetis made misleading statements and failed to disclose issues regarding its veterinary …
Glancy Prongay Wolke & Rotter LLP is urging Zoetis Inc. (ZTS) shareholders who suffered losses between January 14, 2025, and May 6, 2026, to contact them regarding a securities fraud lawsuit. The lawsuit alleges that Zoetis made misleading statements and failed to disclose issues …
LOS ANGELES, July 20, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming July 27, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Zoetis …
Sharemaestro market context Price below Trend Line 52 weeks -52.3%The Rosen Law Firm is urging Zoetis Inc. (NYSE: ZTS) stockholders who incurred losses exceeding $100,000 to contact them regarding a class action lawsuit. The lawsuit alleges that Zoetis made misleading statements about the performance of its animal health products, including Librela, Simparica Trio, …
LOS ANGELES, July 20, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Zoetis Inc. (“Zoetis” or “the Company”) (NYSE: ZTS) for violations of §§10(b) and 20(a) of the Securities Exchange …
Sharemaestro market context Price below Trend Line 52 weeks -54.2%Search by ticker symbol or company name and select a result to open its chart.